Efficacy and mechanism of essential oil from Abies holophylla leaf on airway inflammation in asthma: Network pharmacology and in vivo study

N Park, SJ Park, MH Kim, WM Yang - Phytomedicine, 2022 - Elsevier
Background Asthma is one of the most common chronic inflammatory diseases of the
airways. Essential oil from Abies holophylla leaf (EOA) has been reported to have anti …

Efficacy and mechanism of essential oil from Abies holophylla leaf on airway inflammation in asthma: Network pharmacology and in vivo study

N Park, SJ Park, MH Kim, WM Yang - Phytomedicine, 2022 - khu.elsevierpure.com
Background: Asthma is one of the most common chronic inflammatory diseases of the
airways. Essential oil from Abies holophylla leaf (EOA) has been reported to have anti …

Efficacy and mechanism of essential oil from Abies holophylla leaf on airway inflammation in asthma: Network pharmacology and in vivo study.

N Park, SJ Park, MH Kim, WM Yang - … : International Journal of …, 2021 - europepmc.org
Background Asthma is one of the most common chronic inflammatory diseases of the
airways. Essential oil from Abies holophylla leaf (EOA) has been reported to have anti …

Efficacy and mechanism of essential oil from Abies holophylla leaf on airway inflammation in asthma: Network pharmacology and in vivo study

N Park, SJ Park, MH Kim… - … : international journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Asthma is one of the most common chronic inflammatory diseases of the
airways. Essential oil from Abies holophylla leaf (EOA) has been reported to have anti …

Efficacy and mechanism of essential oil from Abies holophylla leaf on airway inflammation in asthma: network pharmacology and in vivo study.

N Park, SJ Park, MH Kim, WM Yang - 2022 - cabidigitallibrary.org
Background: Asthma is one of the most common chronic inflammatory diseases of the
airways. Essential oil from Abies holophylla leaf (EOA) has been reported to have anti …

[引用][C] Efficacy and mechanism of essential oil from Abies holophylla leaf on airway inflammation in asthma: Network pharmacology and in vivo study

N Park, SJ Park, MH Kim, WM Yang - 2022